$RRX · REGAL REXNORD CORP
Regal Rexnord filed its Q3 2026 10-Q, reporting net sales of $1,588.0M (+6.1% YoY, all organic) and a GAAP net loss of $12.5M ($0.19/share) versus net income of $79.6M ($1.20/share) in Q3 2025. The loss was driven by a $119.3M non-cash goodwill impairment in the Automation & Motion Control segment related to the AMS reporting unit, which is now classified as held for sale. Excluding the impairment, operating income would have been $200.7M; the company also continued deleveraging, with long-term debt down $337.1M from year-end 2025.
- Q3 net loss of $12.5M ($0.19/share) vs. net income of $79.6M ($1.20/share) in Q3 2025, driven entirely by a $119.3M goodwill impairment in the Automation & Motion Control segment.
- Consolidated Q3 net sales rose 6.1% YoY to $1,588.0M, with organic sales up 6.1% led by a $101.2M increase in AMC.
- The goodwill impairment consists of $95.5M from a quantitative test of the AMS reporting unit and $23.8M after AMS was classified as held for sale.
- Gross margin expanded slightly to 37.2% from 37.0% YoY; IPS segment gross margin improved to 42.3% from 41.4%.
- Long-term debt declined to $4,427.5M from $4,764.6M at year-end 2025, reflecting continued deleveraging.
Stock surged +11.86% to $180.01 in the regular session despite the GAAP loss, suggesting investors focused on the non-cash nature of the impairment and the 6.1% organic growth signal. The after-hours session has not yet produced a material extended-hours move beyond the regular-session close.
A $119.3M impairment and held-for-sale classification signal a strategic portfolio exit, while 6.1% organic growth shows the remaining business is accelerating — a split narrative that demands investor attention.
The 6.1% organic growth in industrial automation contrasts with mixed macro signals across the industrial sector. The AMS divestiture and goodwill write-down suggest portfolio rationalization similar to peers shedding non-core assets post-M&A.
The AMS business within AMC is now classified as held for sale, with full goodwill impairment recognized. The filing flags risks around achieving expected benefits from the Altra integration, substantial indebtedness ($4.43B), and dependence on key suppliers amid tariff and trade policy uncertainty.